Showing results (161-170 of 187) with videos related to
Sort By:
Pageof 19
Rheumatology (Oxford, England)|February 27, 2023
Induction failure in granulomatosis with polyangiitis: a nationwide case-control study of risk factors and outcomesBoris Sorin, Michele Iudici, Mary-Jane Guerry, et al.Rheumatology (Oxford, England)|May 24, 2015
Granulomatosis with polyangiitis: endoscopic management of tracheobronchial stenosis: results from a multicentre experienceBenjamin Terrier, Agnès Dechartres, Charlotte Girard, et al.Annals of Internal Medicine|June 2, 2020
Long-Term Rituximab Use to Maintain Remission of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Randomized TrialPierre Charles, Élodie Perrodeau, Maxime Samson, et al.Arthritis & Rheumatology (Hoboken, N.J.)|October 17, 2015
Intravenous Immunoglobulin as an Immunomodulating Agent in Antineutrophil Cytoplasmic Antibody-Associated Vasculitides: A French Nationwide Study of Ninety-Two PatientsEtienne Crickx, Irène Machelart, Estibaliz Lazaro, et al.Rheumatology (Oxford, England)|December 21, 2020
Significance of PR3-ANCA positivity in eosinophilic granulomatosis with polyangiitis (Churg-Strauss)Matthias Papo, Renato A Sinico, Vítor Teixeira, et al.Arthritis & Rheumatology (Hoboken, N.J.)|February 9, 2026
Prediction of Relapse and Glucocorticoid Dependence in Eosinophilic Granulomatosis with Polyangiitis: Findings from a Large European CohortMatthias Papo, Pauline Martinot, Renato A Sinico, et al.Clinical Journal of the American Society of Nephrology : CJASN|July 30, 2020
Developments in the Histopathological Classification of ANCA-Associated GlomerulonephritisEmma E van Daalen, Maria A C Wester Trejo, Arda Göçeroğlu, et al.Health Technology Assessment (Winchester, England)|September 26, 2022
Plasma exchange and glucocorticoids to delay death or end-stage renal disease in anti-neutrophil cytoplasm antibody-associated vasculitis: PEXIVAS non-inferiority factorial RCTDavid Jayne, Michael Walsh, Peter A Merkel, et al.Journal of Autoimmunity|November 16, 2024
Glucocorticoids versus glucocorticoids plus cyclophosphamide in eosinophilic granulomatosis with polyangiitis with poor-prognosis factorsBoris Sorin, Matthias Papo, Renato A Sinico, et al.Rheumatology (Oxford, England)|May 24, 2025
Glucocorticoids vs glucocorticoids plus cyclophosphamide in eosinophilic granulomatosis with polyangiitis without poor-prognosis factors: a target trial emulation studyBoris Sorin, Matthias Papo, Renato Alberto Sinico, et al.Pageof 19